Krystal Biotech Inc (KRYS)

EBITDA

$67.65M

Quarterly · Period ending: · USD

KRYS logo

KRYS EBITDA

Latest reported$67.65M
KRYS Quarterly EBITDA (-$322.00K → $67.65M)
High-resolution chart · PNG

KRYS ebitda history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Krystal Biotech Inc EBITDA — Quarterly (USD)
Period endingEBITDA (USD)
67,645,000
63,168,000
39,606,000
49,576,000
48,318,000
45,231,000
50,165,000
36,462,000
23,087,000
7,425,000
12,164,000
82,112,000
-31,732,000
-35,012,000
-30,963,000
-28,875,000
-27,132,000
-48,950,000
-21,022,000
-14,806,000
-15,697,000
-13,784,000
-9,930,000
-9,133,000
-6,361,000
-4,929,000
-5,904,000
-5,151,000
-5,715,000
-4,562,000
-4,298,000
-2,972,000
-2,449,000
-2,277,000
-1,508,000
-2,088,000
-712,000
-464,000
-619,000
-322,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.